For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View

Sponsor Spike Success.

Curium to Acquire Lantheus in $8 Billion All-Cash Deal

Aug 4, 2026
Curium to Acquire Lantheus in $8 Billion All-Cash Deal

Curium, supported by CapVest Partners, is set to acquire Lantheus, a prominent US radiopharmaceutical company, in a significant all-cash transaction valued at nearly $8 billion. This will transition Lantheus, currently listed on Nasdaq, into a private entity. Under the terms of the agreement, Curium US will purchase all outstanding shares of Lantheus at a price of $102.50 per share upon closing. Additionally, Lantheus shareholders will receive non-transferable contingent value rights (CVRs) that could yield up to an extra $12.00 per share if specific commercial milestones are achieved by 2030, bringing the total potential consideration per share to $114.50.

The offer represents a notable 38% premium over Lantheus’ 60-day volume-weighted average price and a 29% premium over its 30-day average. It is also 21% above the company's closing price on May 21, 2026, the last trading day before reports of the potential sale surfaced. The proposed transaction has garnered unanimous approval from Lantheus’ Board of Directors.

For Your Trading Desk
Trading Journals
Click For Trade View
Desk Accessories
Click For Trade View

Sponsor Spike Success.

Mary Anne Heino, executive chair and CEO of Lantheus, expressed that this transaction validates the company’s achievements over seven decades in radiopharmaceutical innovation. She emphasized that the merger with Curium combines two pioneering companies with complementary strengths, aiming to enhance patient access to vital diagnostics and therapeutics.

Curium CEO Renaud Dehareng highlighted that Lantheus is an ideal partner to accelerate Curium's growth strategy. He noted that the merger would integrate Curium’s theranostics capabilities with Lantheus’ US radiodiagnostics business, enhancing their offerings in , neurology, and cardiology across more than 70 countries. Dehareng stated that the combination would provide a broader range of theragnostic options, from SPECT and PET diagnostics to targeted radioligand therapies, ultimately reaching more patients and clinicians globally.

The acquisition will be financed through a combination of debt and equity, with no financial conditions attached. The companies anticipate that the merger will close in the first half of 2027, subject to regulatory approvals and the consent of Lantheus’ shareholders. Until the transaction is finalized, Lantheus will continue to operate as an independent, publicly listed company.

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View

Sponsor Spike Success.

Recommended for You
Wall Street Rallies Over 1,000 Points After Democratic Election Wins
Breaking Market News Nov 4, 2026

Wall Street Rallies Over 1,000 Points After Democratic Election Wins

Wall Street experienced a significant rally, with the Dow Jones Industrial Average surging over 1,000 points following the Democrats'…

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View
Desk Accessories

Monitor stands and desk organizers for a trading setup with fewer loose ends.

Click For Trade View
Market Microstructure & Order Flow

Books on liquidity, order books, spreads, and trade execution. A closer look at what happens between clicking and getting filled.

Click For Trade View
Algorithmic Trading & Python

Coding and research books for systematic traders. Backtests deserve scrutiny, not a victory lap.

Click For Trade View
Financial Statements & Earnings Research

References for reading earnings reports, cash flow, and balance sheets. The headline rarely brings all the footnotes.

Click For Trade View

Sponsor Spike Success.

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)